Cargando…

Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method

According to the predominant theories, soluble amyloid-beta (Aβ) aggregates are the principal neurotoxic agents in Alzheimer’s disease pathology, making them a popular target for the development of therapeutics and diagnostic markers. One of the most commonly used methods for determining the concent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssen, Leen, Sobott, Frank, De Deyn, Peter P., Van Dam, Debby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487349/ https://www.ncbi.nlm.nih.gov/pubmed/26150979 http://dx.doi.org/10.1016/j.mex.2015.02.011

Ejemplares similares

Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta
por: Akbor, Maruf Mohammad, et al.
Publicado: (2021)

Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
por: Yamin, Rina, et al.
Publicado: (2009)

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide
por: Molina-Fernández, Rubén, et al.
Publicado: (2022)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow
por: Choi, Yoon Jung, et al.
Publicado: (2013)

Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus
por: Whitcomb, Daniel J., et al.
Publicado: (2015)

Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
por: Wolff, Martin, et al.
Publicado: (2015)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Short-Term Pharmacological Induction of Arterial Stiffness and Hypertension with Angiotensin II Does Not Affect Learning and Memory and Cerebral Amyloid Load in Two Murine Models of Alzheimer’s Disease
por: Hendrickx, Jhana O., et al.
Publicado: (2022)

Reference interval and the role of plasma oligomeric beta amyloid in screening of risk groups for cognitive dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2021)

Enhanced oligomerization of full-length RAGE by synergy of the interaction of its domains
por: Moysa, Alexander, et al.
Publicado: (2019)

Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain
por: Arbel-Ornath, Michal, et al.
Publicado: (2017)

Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A
por: Patke, Sanket, et al.
Publicado: (2013)

Ultrafast propagation of β-amyloid fibrils in oligomeric cloud
por: Ogi, Hirotsugu, et al.
Publicado: (2014)

Structural mapping of oligomeric intermediates in an amyloid assembly pathway
por: Karamanos, Theodoros K, et al.
Publicado: (2019)

Oligomerization by co-assembly of β-amyloid and α-synuclein
por: Kim, Jin Ryoun
Publicado: (2023)

Cysteine-rich domain of scavenger receptor Al modulates the efficacy of surface targeting and mediates internalization of oligomeric beta amyloid
por: Tsay, Huey-Jen
Publicado: (2013)

Effects of α-Lipoic Acid on Phagocytosis of Oligomeric Beta-Amyloid(1–42) in BV-2 Mouse Microglial Cells
por: Ko, Chih-Yuan, et al.
Publicado: (2022)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
por: Sanchez-Varo, Raquel, et al.
Publicado: (2021)

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
por: Buniatian, Gayane Hrachia, et al.
Publicado: (2020)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin
por: Sirangelo, Ivana, et al.
Publicado: (2020)

Amyloid-β oligomerization monitored by single-molecule stepwise photobleaching
por: Dresser, Lara, et al.
Publicado: (2021)

Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
por: Qian, Zhenyu, et al.
Publicado: (2022)

Systemic Administration of Substance P Recovers Beta Amyloid-Induced Cognitive Deficits in Rat: Involvement of Kv Potassium Channels
por: Campolongo, Patrizia, et al.
Publicado: (2013)

Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease
por: Wostyn, Peter, et al.
Publicado: (2011)

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes
por: Vermeiren, Yannick, et al.
Publicado: (2018)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro
por: Zhao, Jiaying, et al.
Publicado: (2017)

Extracellular vesicles: where the amyloid precursor protein carboxyl‐terminal fragments accumulate and amyloid‐β oligomerizes
por: Pérez‐González, Rocío, et al.
Publicado: (2020)

A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012)

Infrared nanospectroscopy characterization of oligomeric and fibrillar aggregates during amyloid formation
por: Ruggeri, F. S., et al.
Publicado: (2015)

GM(1) Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
por: Amaro, Mariana, et al.
Publicado: (2016)

Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid
por: Asam, Kesava, et al.
Publicado: (2017)

Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A(2) in a spatial-specific manner
por: Palavicini, Juan Pablo, et al.
Publicado: (2017)

Wnt Signaling Rescues Amyloid Beta-Induced Gut Stem Cell Loss
por: Kaur, Prameet, et al.
Publicado: (2022)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aobhegglddofkpsn1piqke20oj